Speakers

Albert Ribickas

Associate Director, Operations, Cell Therapy Facility

Moffitt Cancer Center

Amnon Eylath

VP, Head of Quality

Minovia Therapeutics

Amol Thote

Senior Director

Bayer

Austin Bigley

VP, R&D

Indapta Therapeutics

Barbra Sasu

CSO

Allogene

Beatriz Aranda Orgilles

Team Leader

Cellectis

Bertie MacArthur

Account Manager

Beacon Targeted Therapies

Blake Aftab

CSO

Adicet Bio Inc.

Cédric Cleyrat

Scientific Director Cell Therapy Engineering Strategy & Innovation

Bristol Myers Squibb

Charles Nicolette

CEO

CoImmune

Cokey Nguyen

CSO

Atara Biotherapeutics

Colleen Delaney

Scientific Founder, EVP of R&D

Deverra Therapeutics

Derek Tan

Member, Tri-institutional Professor, Chair, Chemical Biology Program

Memorial Sloan Kettering Cancer Center

Donna Rill

CTO

Triumvira Immunlolgics

Ebba Sohlberg

Project Manager

Karolinska Institutet

Elisa Gambini

CTO-COO

Oloker Therapeutics

Elizabeth Garner

Director - T Cell Therapeutics

Caribou Biosciences

Erika Von Euw

President

Deverra Therapeutics

Evren Alici

Associate Professor, Co-Director, NextGenNK Competence Center

Karolinska Institutet

Guanghui Hu

CEO

Naki Therapeutics

Hina Chaudhry

Professor of Medicine

Icahn School of Medicine at Mount Sinai

Jason Acker

Associate VP, Professor, Laboratory Medicine and Pathology

University of Alberta

Jeff Liter

President, CEO

Luminary Therapeutics

Jim Green

Senior Director, Engineering and Automation

Bayer

Joseph Gold

VP, Technical Operations

Catamaran Bio

Joy Zhou

VP

Mink Therapeutics

Kate Rochlin

COO

IN8Bio

Ken Chrobak

SVP of CMC

Wugen

Luis Borges

CSO

Century Tx

Luke Pase

CTO

Anocca

Marco Alessandrini

CTO

Antion Biosciences

Mark Frattini

CMO

Cellectis

Mark Throsby

COO/CSO

Gadeta

Michael Baker

CEO

Arovella Therapeutics

Noelle Hutchins

Associate

Omega Funds

Omid Veiseh

Co-Founder and Chief Scientific Advisor

Avenge Bio

Oscar Segurado

CMO

ASC Therapeutics

Renier J. Brentjens

Deputy Director

Roswell Park Comprehensive Cancer Center

Richard Lopez

CEO

PhosphoGam

Rick Morgan

CSO

Be Biopharma

Sai-Wen Tang

R&D Director

Acepodia

Samuel Zhang

CBO

Gracellbio Biotechnologies

Stephen Chen

CTO

Tevogen Bio

Sumona Sarkar

Biomedical Engineer

NIST

Tirtha Chakraborty

CSO

Vor Biopharma

Tracey Turner

Scientist, Formulation & Cryobiology in the Cell Therapy Development Organization,

Bristol Myers Squibb

Uday Kumar K

VP– Technical Operation

Stempeutics Research Pvt Ltd

Veronica Ricci

QA&RA

Oloker Therapeutics

William Van Der Touw

Senior VP Translational Research

Celularity Inc.

Yu Qian

Associate Director, Oncology Cell Therapy Technology and Product Engine

Takeda

FULL EVENT GUIDE
CONFERENCE DAY ONE